These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30963672)

  • 41. Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction.
    Fayyaz AU; Edwards WD; Maleszewski JJ; Konik EA; DuBrock HM; Borlaug BA; Frantz RP; Jenkins SM; Redfield MM
    Circulation; 2018 Apr; 137(17):1796-1810. PubMed ID: 29246894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension.
    Strauss B; Sassi Y; Bueno-Beti C; Ilkan Z; Raad N; Cacheux M; Bisserier M; Turnbull IC; Kohlbrenner E; Hajjar RJ; Hadri L; Akar FG
    J Mol Cell Cardiol; 2019 Feb; 127():20-30. PubMed ID: 30502350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
    Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
    J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy.
    Schermuly RT; Pullamsetti SS; Kwapiszewska G; Dumitrascu R; Tian X; Weissmann N; Ghofrani HA; Kaulen C; Dunkern T; Schudt C; Voswinckel R; Zhou J; Samidurai A; Klepetko W; Paddenberg R; Kummer W; Seeger W; Grimminger F
    Circulation; 2007 May; 115(17):2331-9. PubMed ID: 17438150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
    Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characteristics and risk factors for pulmonary arterial hypertension associated with primary Sjögren's syndrome: 15 new cases from a single center.
    Zhang N; Zhao Y; Wang H; Sun W; Chen M; Fan Q; Yang Z; Wei W
    Int J Rheum Dis; 2019 Sep; 22(9):1775-1781. PubMed ID: 31368254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Leptin signalling system as a target for pulmonary arterial hypertension therapy.
    Huertas A; Tu L; Thuillet R; Le Hiress M; Phan C; Ricard N; Nadaud S; Fadel E; Humbert M; Guignabert C
    Eur Respir J; 2015 Apr; 45(4):1066-80. PubMed ID: 25745038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcium-Sensing Receptor Arbitrates Hypoxia-Induced Proliferation of Pulmonary Artery Smooth Muscle Cells via the G Protein-PLC-IP3 Pathway.
    Zhang H; Chang Z; Mehmood K; Yang K; Liu Z; Duan Z; Yuan F; Jiao Z; Liu W; Gao T; Pei X; Ijaz M; Ghori MT; Tian Y; Guo R
    Crit Rev Eukaryot Gene Expr; 2019; 29(1):69-76. PubMed ID: 31002596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identifying microRNAs targeting Wnt/β-catenin pathway in end-stage idiopathic pulmonary arterial hypertension.
    Wu D; Talbot CC; Liu Q; Jing ZC; Damico RL; Tuder R; Barnes KC; Hassoun PM; Gao L
    J Mol Med (Berl); 2016 Aug; 94(8):875-85. PubMed ID: 27188753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Severe Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin Deficiency.
    Sweatt AJ; Miyagawa K; Rhodes CJ; Taylor S; Del Rosario PA; Hsi A; Haddad F; Spiekerkoetter E; Bental-Roof M; Bland RD; Swietlik EM; Gräf S; Wilkins MR; Morrell NW; Nicolls MR; Rabinovitch M; Zamanian RT
    Chest; 2021 Oct; 160(4):1442-1458. PubMed ID: 34181952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced osteopontin expression in a murine model of allergen-induced airway remodelling.
    Kohan M; Bader R; Puxeddu I; Levi-Schaffer F; Breuer R; Berkman N
    Clin Exp Allergy; 2007 Oct; 37(10):1444-54. PubMed ID: 17883724
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HMGB1/TLR4 promotes hypoxic pulmonary hypertension via suppressing BMPR2 signaling.
    Wang J; Tian XT; Peng Z; Li WQ; Cao YY; Li Y; Li XH
    Vascul Pharmacol; 2019 Jun; 117():35-44. PubMed ID: 30610955
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension.
    Tamura Y; Phan C; Tu L; Le Hiress M; Thuillet R; Jutant EM; Fadel E; Savale L; Huertas A; Humbert M; Guignabert C
    J Clin Invest; 2018 May; 128(5):1956-1970. PubMed ID: 29629897
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Osteopontin predicts adverse right ventricular remodelling and dysfunction in pulmonary hypertension.
    Rosenberg M; Meyer FJ; Gruenig E; Lutz M; Lossnitzer D; Wipplinger R; Katus HA; Frey N
    Eur J Clin Invest; 2012 Sep; 42(9):933-42. PubMed ID: 22500728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic inflammation within the vascular wall in pulmonary arterial hypertension: more than a spectator.
    Huertas A; Tu L; Humbert M; Guignabert C
    Cardiovasc Res; 2020 Apr; 116(5):885-893. PubMed ID: 31813986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
    Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LncRNA-TCONS_00034812 in cell proliferation and apoptosis of pulmonary artery smooth muscle cells and its mechanism.
    Liu Y; Sun Z; Zhu J; Xiao B; Dong J; Li X
    J Cell Physiol; 2018 Jun; 233(6):4801-4814. PubMed ID: 29150946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pristane/Hypoxia (PriHx) Mouse as a Novel Model of Pulmonary Hypertension Reflecting Inflammation and Fibrosis.
    Mori H; Ishibashi T; Inagaki T; Okazawa M; Masaki T; Asano R; Manabe Y; Ohta-Ogo K; Narazaki M; Ishibashi-Ueda H; Kumanogoh A; Nakaoka Y
    Circ J; 2020 Jun; 84(7):1163-1172. PubMed ID: 32522898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Association between serum levels of osteopontin and systolic pulmonary artery pressure among healthy adults post acute high altitude exposure].
    Yang YQ; Liu C; Yang J; Gao XB; Zhang JH; Shen Y; Huang L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jun; 48(6):489-494. PubMed ID: 32842259
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.